Prevalence of KRAS, NRAS, and BRAF gene mutations in metastatic colorectal cancer (mCRC) patients: a systematic literature review and meta-analysis

被引:0
|
作者
Bylsma, Lauren C. [1 ]
Levin-Sparenberg, Elizabeth D. [2 ]
Lowe, Kimberly [3 ]
Sangare, Laura [4 ]
Fryzek, Jon [5 ]
Alexander, Dominik D. [2 ]
机构
[1] EpidStrategies, Ann Arbor, MI USA
[2] EpidStat Inst, Ann Arbor, MI USA
[3] Amgen Inc, Seattle, WA USA
[4] SimulStat, Portland, OR USA
[5] EpidStrategies, Rockville, MD USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
906
引用
收藏
页码:440 / 440
页数:1
相关论文
共 50 条
  • [1] A Systematic Literature Review and Meta-Analysis Describing the Prevalence of KRAS, NRAS, and BRAF Gene Mutations in Metastatic Colorectal Cancer
    Levin-Sparenberg, Elizabeth
    Bylsma, Lauren C.
    Lowe, Kimberly
    Sangare, Laura
    Fryzek, Jon P.
    Alexander, Dominik D.
    GASTROENTEROLOGY RESEARCH, 2020, 13 (05) : 184 - 198
  • [2] Prevalence of KRAS, NRAS, and BRAF gene mutations in metastatic colorectal cancer patients: A systematic literature review and meta-analysis.
    Lowe, Kimberly
    Bylsma, Lauren C.
    Levin-Sparenberg, Elizabeth D.
    Sangare, Laura
    Fryzek, Jon
    Alexander, Dominik D.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [3] KRAS and BRAF mutations in Iranian colorectal cancer patients: A systematic review and meta-analysis
    Yari, Abolfazl
    Afzali, Asiyeh
    Aalipour, Mostafa
    Nakheai, Mehran
    Zahedi, Mohammad Javad
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2020, 11 (04) : 355 - 369
  • [4] Treatment and survival of patients with de novo metastatic colorectal cancer (mCRC) rested for KRAS, NRAS or BRAF mutations
    Booker, Ben D.
    Markt, Sarah C.
    Schumacher, Fredrick R.
    Rose, Johnie
    Cooper, Greg S.
    Selfridge, J. Eva
    Koroukian, Siran M.
    CANCER RESEARCH, 2022, 82 (12)
  • [5] Prevalence of RAS and BRAF mutations in metastatic colorectal cancer patients by tumor sidedness: A systematic review and meta-analysis
    Bylsma, Lauren C.
    Gillezeau, Christina
    Garawin, Tamer A.
    Kelsh, Michael A.
    Fryzek, Jon P.
    Sangare, Laura
    Lowe, Kimberly A.
    CANCER MEDICINE, 2020, 9 (03): : 1044 - 1057
  • [6] Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysis
    Passiglia, Francesco
    Bronte, Giuseppe
    Bazan, Viviana
    Galvano, Antonio
    Vincenzi, Bruno
    Russo, Antonio
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 99 : 150 - 157
  • [7] Is antiangiogenic therapy necessary for patients with metastatic colorectal cancer (mCRC) and mutation in the BRAF gene? Results of the systematic review and meta-analysis
    Fedyanin, Mikhail
    Polyanskaya, Elizaveta
    Elsnukaeva, Kheda
    Tryakin, Alexey
    Pokataev, Ilya
    Tjulandin, Sergei
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [8] Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection: A Systematic Review and Meta-Analysis
    Tosi, Federica
    Magni, Elena
    Amatu, Alessio
    Mauri, Gianluca
    Bencardino, Katia
    Truini, Mauro
    Veronese, Silvio
    De Carlis, Luciano
    Ferrari, Giovanni
    Nichelatti, Michele
    Sartore-Bianchi, Andrea
    Siena, Salvatore
    CLINICAL COLORECTAL CANCER, 2017, 16 (03) : E153 - E163
  • [9] Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patients
    Hsu, Hung-Chih
    Thiam, Tan Kien
    Lu, Yen-Jung
    Yeh, Chien Yuh
    Tsai, Wen-Sy
    You, Jeng Fu
    Hung, Hsin Yuan
    Tsai, Chi-Neu
    Hsu, An
    Chen, Hua-Chien
    Chen, Shu-Jen
    Yang, Tsai Sheng
    ONCOTARGET, 2016, 7 (16) : 22257 - 22270
  • [10] Distinct impacts of KRAS, NRAS and BRAF mutations on survival of patients with metastatic colorectal cancer
    Wang, Yucai
    Loree, Jonathan M.
    Yu, Cecilia
    Tschautscher, Marcella
    Briggler, Andrew M.
    Overman, Michael J.
    Broaddus, Russell
    Meric-Bernstam, Funda
    Jones, Jeremy Clifton
    Balcom, Jessica
    Kipp, Benjamin
    Kopetz, Scott
    Grothey, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)